Giuseppe P. Novelli

Is
Pozzilli, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 339 publications

ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health.

ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health.

Journal: Human genomics

Published: May 18, 2026

Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in Italy.

Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in Italy.

Journal: Journal of medical economics

Published: April 27, 2026

Frailty in elderly with a rare genetic disease: a geriatric score analysis in C1 inhibitor Hereditary Angioedema.

Frailty in elderly with a rare genetic disease: a geriatric score analysis in C1 inhibitor Hereditary Angioedema.

Journal: Frontiers in medicine

Published: March 20, 2026

Unmasking Brugada ECG Pattern in Myotonic Dystrophy Type 2 With an ANK2 Variant.

Unmasking Brugada ECG Pattern in Myotonic Dystrophy Type 2 With an ANK2 Variant.

Journal: Pacing and clinical electrophysiology : PACE

Published: February 06, 2026

Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health.

Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health.

Journal: Nature reviews. Urology

Published: February 04, 2026

Cost-Effectiveness of Elranatamab Versus Teclistamab for the Management of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma in Italy.

Cost-Effectiveness of Elranatamab Versus Teclistamab for the Management of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma in Italy.

Journal: Cancers

Published: January 30, 2026

The MEG3-miRNA regulatory axis could potentially modulate response to biological therapies in psoriatic arthritis.

The MEG3-miRNA regulatory axis could potentially modulate response to biological therapies in psoriatic arthritis.

Journal: Pharmacological reports : PR

Published: December 23, 2025

The novel (TCTG)n motif in CNBP expanded alleles: composition, dynamics and genotype-phenotype correlation in Myotonic dystrophy type 2 (DM2).

The novel (TCTG)n motif in CNBP expanded alleles: composition, dynamics and genotype-phenotype correlation in Myotonic dystrophy type 2 (DM2).

Journal: Human genomics

Published: December 22, 2025

Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy.

Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy.

Journal: European journal of human genetics : EJHG

Published: December 20, 2025

Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?

Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?

Journal: Microorganisms

Published: November 12, 2025

Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy.

Longitudinal Multimodal Assessment of Structure and Function in INPP5E-Related Retinopathy.

Journal: Genes

Published: November 09, 2025

An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility.

An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility.

Journal: Genes

Published: November 05, 2025

Showing 1-12 of 339

Last Updated: 09/26/2026